Carcinoma of esophagus related gene-2 and use of coding protein thereof

A kind of use, recombinant plasmid technology, applied in gene therapy, medical preparations containing active ingredients, genetic material components, etc., can solve problems such as undiscovered genes

Inactive Publication Date: 2004-03-24
CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, there have been many studies on esophageal cancer, but no genes related to the occurrence and development of esophageal cancer have been found among the oncogenes and tumor suppressor genes in esophageal cancer (Shih Hsin Lu. Alterations of oncogenes and tumorsuppressor genes in esophageal cancer in China. Mutation Research 2000, 467, 343-353)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carcinoma of esophagus related gene-2 and use of coding protein thereof
  • Carcinoma of esophagus related gene-2 and use of coding protein thereof
  • Carcinoma of esophagus related gene-2 and use of coding protein thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0082] The source and extraction and purification of ECRG-2 gene

[0083] mRNA differential display

[0084] (1) Extraction of total RNA (TotalRNA) from tissue samples

[0085] 1. Refer to "one-step extraction method of guanidine isothiocyanate" ("Modern Molecular Biology Experimental Technology" edited by Lu Shengdong, China Peking Union Medical College Press, 139-141), the specific steps have been modified.

[0086] Take 0.3g of frozen tissue specimen, grind it into powder in a mortar in the presence of liquid nitrogen, and transfer it to 3ml of solution D (4M guanidine isothiocyanate, 25mM sodium citrate pH7.0, 0.5% lauryl inosine Sodium phosphate, 100mM 2-mercaptoethanol) homogenate in a homogenizer (operate in an ice bath), transfer the homogenate into a 10ml centrifuge tube, and add in order: 0.3ml 2M sodium acetate pH4.0; 3ml water-saturated phenol; 0.6ml of heliumform-isoamyl alcohol (49:1), shake vigorously for 10 seconds immediately after capping, place in ice ba...

Embodiment 2

[0152] Expression of fusion protein encoded by ECRG2 gene in Escherichia coli

[0153] Obtaining ECRG-2 Gene by PCR

[0154] Obtain the ECRG-2 gene fragment encoding 85 amino acids. Add the following reagents to the PCR reaction tube.

[0155] Reagent per tube (ul)

[0156] TAKARALATaq 0.25ul

[0157] 10×LA BUFFER (Mg 2+ Plus) 2.5ul

[0158] dNTP (2.5mM) 4ul

[0159]DNA 1ul

[0160] ECRG-25'primer (10mM) 1ul

[0161] ECRG-23'primer (10mM) 1ul

[0162] wxya 2 O 14.75ul

[0163] 25ul

[0164] Put it in a PCR machine (2400 type of PE company): after denaturation at 94°C for 4 minutes, denaturation at 94°C for 30 seconds, annealing at 59°C for 45 seconds, extension at 72°C for 1 minute, a total of 35 cycles, and finally 72°C for 7 minutes, 4 ℃ insulation.

[0165] The amplification results were detected by 1% agarose gel electrophoresis.

[0166] Cloning and purification of PCR products

[0167] 1. Restriction endonuclease digestion of PCR products and vectors ...

Embodiment 3

[0205] Effect of ECRG2 Gene on Growth and Cell Cycle of Bel7402 Cells

[0206] Construction of recombinants

[0207] Use specific primers (ECRG-25'-primer: TGG G GAT CCC ATG AAG ATC ACTGGG GGT CTC; 3'-primer: TCG AAT TCC TTA GCA ACT TCC ATC GTG AAG) to do PCR amplification of ECRG-2 gene, using ECORI , Insert the vector pcDNA3.1(+) after digestion with BamHI. The recombinant was transformed into Escherichia coli DH5α, and the plasmid was extracted from the positive clone. The positive recombinant was identified by enzyme digestion and sent to the company for sequencing.

[0208] cell culture

[0209] The Bel7402 cell line was cultured in DMEM medium containing 10% newborn calf serum, 5% CO2, and 37°C.

[0210] Transfection experiment

[0211]1. Inoculate an appropriate amount of Bel7402 cells in a 35mm dish until it grows to 80% full. Dilute 2ug of pcDNA3.1(+)-ECRG2 into 100ul of serum-free DMEM medium (solution A), then dilute 5ul of LIPOFECTAMINE™ into 100ul of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to the field of gene related to carcinoma of esophagus, in particular, it relates to nucleotide sequence of gene-2(ECRG-2) related to carcinoma of esophagus. Said invention also relates to the recombinant carrier containing the described polynucleotide sequence and colibacillus containing said carrier. Said invention also further relates to the application of the esophagus carcinoma related gene-2 nucleotide sequence coded protein, and the growth speed of tumor cell transfected by said ECRG-2 polynucleotide sequence can be obviously reduced, and its death is increased.

Description

technical field [0001] The invention relates to the field of esophageal cancer-related genes, in particular to the nucleotide sequence of esophageal cancer-related gene-2 ​​(ECRG-2). The present invention also relates to a recombinant vector containing the polynucleotide sequence and Escherichia coli containing the vector. The present invention further relates to the use of the protein encoded by the esophageal cancer-related gene-2 ​​nucleotide sequence. The tumor cell growth speed transfected with the ECRG-2 polynucleotide sequence obviously decreases, and the apoptosis increases. Background technique [0002] Tumor is one of the important diseases that threaten human health. Esophageal cancer is one of the most common malignant tumors, and 50% of the world's esophageal cancers occur in China. In recent years, there have been many studies on esophageal cancer, but no genes related to the occurrence and development of esophageal cancer have been found among the oncogenes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7088A61K48/00A61P35/00C07H21/00C12N15/11C12N15/63C12N15/74
Inventor 陆士新
Owner CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap